Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-132-3 | CAS number: 78-67-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study (OECD 423)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- yes
- Remarks:
- The temperature and relative humidity recorded in the animal room were sometimes outside of the target ranges specified in the study plan
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- yes
- Remarks:
- (see above)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- AZDN
- IUPAC Name:
- AZDN
- Reference substance name:
- 2,2'-dimethyl-2,2'-azodipropiononitrile
- EC Number:
- 201-132-3
- EC Name:
- 2,2'-dimethyl-2,2'-azodipropiononitrile
- Cas Number:
- 78-67-1
- Molecular formula:
- C8H12N4
- IUPAC Name:
- 2,2'-dimethyl-2,2'-azodipropiononitrile
- Details on test material:
- - Name of test material (as cited in study report): AZDN
- Physical state: solid (white powder)
- Analytical purity: 99.2%
- Lot/batch No.: 6089
- Expiration date of the lot/batch: March 2010
- Storage conditions of test material: below 15°C and protected from light
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Breeder: Janvier, Le Genest-Saint-Isle, France.
- Age at study initiation: approximately 9 weeks old for the first assay and 8 weeks old for the next assays
- Weight at study initiation: 215 +/- 23 g
- Fasting period before study: approximately 18 hours
- Housing: polycarbonate cages with stainless steel lid (48 cm x 27 cm x 20 cm)
- Diet (e.g. ad libitum): conventional laboratory diet (SSNIFF R/M-H pelleted maintenance diet)
- Water (e.g. ad libitum): drinking water filtered by a FG Millipore membrane (0.22 micron), provided ad libitum.
- Acclimation period: at least 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2°C
- Humidity (%): 30 to 70%
- Air changes (per hr): 12 cycles/hour
- Photoperiod (hrs dark / hrs light): 12h/12h (7:00 - 19:00)
IN-LIFE DATES: from 21 January 2010 to 17 February 2010
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: sesame oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 30 or 200 mg/kg
- Amount of vehicle (if gavage): 10 mL/kg
- Justification for choice of vehicle: standard vehicle used for specific routes of administration
- Lot/batch no. (if required): 067K0069
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: according to information available on the test item, for animal welfare reasons, the starting dose-level of 300 mg/kg was chosen. - Doses:
- 300 mg/kg and 2000 mg/kg
- No. of animals per sex per dose:
- 3 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: the animals were observed frequently during the hours following administration of the test item, for detection of possible treatment-related clinical signs. Thereafter, observation of the animals was made at least once a day. The animals were weighed individually just before administration of the test item on day 1 and then on days 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight. - Statistics:
- no
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 300 - < 2 000 mg/kg bw
- Mortality:
- Dose-level of 300 mg/kg: none.
Dose-level of 2000 mg/kg: Due to signs of poor clinical conditions observed (hypoactivity, sedation, piloerection, tremors, dyspnea, hypersensitivity to touch and tonic clonic convulsions), the animals were sacrificed on day 1 for ethical reasons. - Clinical signs:
- other: Dose-level of 300 mg/kg (three females then confirmation on three other females) : Hypoactivity, piloerection and rhinorrhea were observed in all the animals on days 1 and/or 2. Rhinorrhea persisted in 2/6 animals on day 3. Tremors and hypersensitivity to
- Gross pathology:
- Macroscopic examination of the main organs of the animals revealed no apparent abnormalities.
- Other findings:
- None.
Applicant's summary and conclusion
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: other: Directive 67/548/EEC and EU CLP No 2008/1272.
- Conclusions:
- Under the experimental conditions of this study, the oral LD50 of the test item AZDN (batch No. 6089, purity: 99.2%) was comprised between 300 and 2000 mg/kg in rats.
According to the classification criteria laid down in Council Directive 67/548/EEC (and subsequent adaptations), the test item AZDN should be assigned the symbol Xn, the indication of danger "Harmful" and the risk phrase R 22: "Harmful if swallowed". - Executive summary:
- The acute oral toxicity of the test item,
AZDN, was evaluated in rats according to OECD (No. 423, 17th December
2001) and Commission Regulation (EC) (No. 440/2008, B1tris, 30 May 2008)
guidelines. The test item was prepared in sesame oil and was administered
by oral route (gavage), under a volume of 10 mL/kg, to groups of three
fasted female Sprague-Dawley rats. Rats were exposed to 300 or 2000 mg/kg bw.
Clinical signs, mortality and body weitht gain were checked for a period
of up to 14 days following the single administration of the test item. All
animals were subjected to necropsy.
Dose-level of 300 mg/kg (three females then confirmation on three other females): No mortality was recorded. Hypoactivity, piloerection and rhinorrhea were observed in all the animals on days 1 and/or 2. Rhinorrhea persisted in 2/6 animals on day 3. Tremors and hypersensitivity to noises and being touched were also noted in 3/6 animals on day 2. When compared to CIT historical control data, a lower body weight gain (vs.±in control data base) was noted in 1/6 females between day 1 and day 8, returning to normal thereafter.
Dose-level of 2000 mg/kg (three females): Hypoactivity then sedation, piloerection, tremors, dyspnea, hypersensitivity to touch and tonic clonic convulsions were observed in all the animals within 4h30 of treatment. Lateral recumbency was also noted in 1/3 animals 3 hours after treatment. In view of these signs of poor clinical conditions, all three animals were sacrificed on day 1 for ethical reasons. At necropsy, no apparent abnormalities were observed in any animal.
Under the experimental conditions of this study, the oral LD50of the test item AZDN (batch No. 6089, purity: 99.2%) was comprised between 300 and 2000 mg/kg in rats. According to the classification criteria laid down in Council Directive 67/548/EEC (and subsequent adaptations),the test item AZDN should be assigned the symbol Xn, the indication of danger "Harmful" and the risk phrase R 22: "Harmful if swallowed", and AZDN in classified in category 4 according to Regulation EC no.1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.